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Abstract 
 
Objective: To explore treatment decision-making experiences of Australian migrants with 
cancer from Arabic, Chinese, or Greek backgrounds and their relatives. 
Methods: 73 patients and 18 caregivers from cancer support groups and oncology clinics 
participated in either a focus group (n=14) or semi-structured interview (n=21) conducted in the 
participant's own language. Participant treatment decision-making preferences were discussed as 
part of patients' overall treatment experience and a thematic analysis conducted.  
Results: Four main themes emerged from the data:(1) perceived role of the patient in 
decision-making;(2) access to information and the impact of language; (3)cultural influences 
(4)family involvement. The majority of participants experienced passive involvement during 
treatment consultations, but expressed a desire for greater involvement. Language rather than 
culture was a greater obstacle to active participation. Difficulty communicating effectively in 
English was the most significant barrier to participation in treatment decisions. To overcome 
language challenges, participants actively sought information from alternative sources. 
Conclusion and practice implications: This study provides new insights into the 
influence of language and culture on the treatment decision-making experiences of migrants with 
cancer and their families within the Australian cancer care system.  To reduce health disparities 
doctors need to address language difficulties and be aware of cultural differences. 
 
Key words: Migrant cancer patient, treatment decision making, share decision-making, 
culture, qualitative research 
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1. Introduction 
  Treatment decision-making is a complex interactive process. Improvements in detection 
and treatment of cancer mean that doctors and their patients are often presented with several 
treatment options and must weigh up the benefits of each against treatment side effects and 
patient-related factors, increasing the complexity of decision-making discussions.  
 
Within the literature there are three broad models of medical decision-making: (1) 
paternalistic (2) informed and (3) shared decision-making (SDM) [1]. These models highlight 
differing levels of patient involvement in decision-making. There is consensus that active 
involvement in treatment decision-making increases patients’ understanding of their illness, 
improves treatment adherence, leads to better health outcomes and increases patient satisfaction 
[2, 3]. In Western cultures shared decision-making (SDM) is generally regarded as a gold 
standard of treatment decision-making as it respects both patients' autonomy and the doctors' 
expertise and avoids unbalanced sharing of power and responsibility[1]. A central tenet of shared 
decision-making is respect for the patient’s preference for level of involvement [4].  
 
Information and communication preferences are key features of treatment decision-
making discussions, however individual patient attitudes are varied and influenced by a number 
of factors, including cultural background and religion [2, 3]. For example in many cultures 
disclosure of diagnostic and prognostic information to the patient is discouraged in an effort to 
protect the patient from distress [5, 6]. Cultural values and communication expectations common 
in non-western cultures [7, 8] may prevail even when patients and families migrate to countries 
with different communication norms.    
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There have been a number of studies investigating differences in doctor-patient 
communication between migrant and non-migrant groups during medical consultations.  These 
studies suggest migrant patients are more passive during medical consultations, ask fewer 
questions and have less understanding of cancer and treatment than non-migrants [2, 5, 9, 10]. 
Other studies suggest migrants' information preferences are dependent upon their level of 
acculturation [11, 12]. However little is known about the preferences of migrants with cancer to 
participate in treatment decision-making discussions. 
 
Australia has one of the most culturally diverse populations in the world, with 26% of 
Australians born overseas and 2% of the population speaking English poorly or not at all [13]. 
Despite this, to date, few studies have investigated the impact of culture on the treatment 
decision-making of Australian migrants. The aim of the current study, therefore, was to explore 
factors that influence the cancer treatment decision-making experiences of first generation 
migrants with cancer from Arabic, Chinese, or Greek backgrounds.  
 
2. Method 
2.1. Participants  
Patients were recruited from community-based cancer support groups and three oncology 
outpatient clinics in Sydney and Melbourne, Australia. Participants were eligible to participate if 
they were a first generation migrant from a Chinese (Cantonese or Mandarin), Greek or Arabic 
speaking country, had one of these languages as their first language, was aged 18 years or over 
and had been diagnosed with cancer within the previous three years or cared for a patient 
3 
 
diagnosed within the preceding three years. These cultural groups were chosen as they represent 
the largest immigrant groups to Australia [12].  
 
2.2. Procedure 
Potentially eligible participants were approached by a support group leader or member of 
their treating team and provided with information about the study in their own language. 
Bilingual research staff obtained written informed consent.  Those who consented to the study 
elected to participate in either a focus group or semi-structured interview conducted by bi-lingual 
researchers. Participant experiences and preferences for treatment decision-making were 
discussed as part of participants’ overall experience of treatment, using open-ended questions and 
more specific probes. The semi-structured questions were informed by the treatment decision-
making and migrant cancer experiences literature. Ethics approval was obtained from the Human 
Research Ethics Committee at the University of Sydney (03-2006/1/8914).  
 
2.3. Data Coding and Analysis  
 Participant discussions were digitally-recorded, translated and transcribed. A thematic 
analysis was conducted based on a grounded theory approach using a constant comparative 
methodology. All three researchers initially coded six randomly selected transcripts and a coding 
framework was developed. A further 14 transcripts were then coded (XZ, JS) to confirm the 
framework and higher order concepts. All inconsistent findings were discussed until consensus 
was reached by the authors. A further 16 focus group and interview transcripts were then coded 
(XZ) to confirm theoretical saturation.  
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3. Results 
Focus groups were approximately 90 minutes and interviews approximately 40 minutes 
in length. Ninety-one participants (73 patients and 18 caregivers) participated in one of 14 focus 
groups (4 Mandarin, 4 Cantonese, 4 Greek and 2 Arabic groups) and 21 interviews (11 Arabic, 7 
Greek, 2 Mandarin, and 1 Cantonese). Table 1 lists the demographic and clinical characteristics 
of the study sample. 
Table 1: Participant demographic and clinical characteristics  
Variable N (%) 
Language  
Greek 22 (22) 
Chinese---Mandarin 23 (26) 
Chinese---Cantonese 26 (29) 
Arabic 20 (21) 
Participant Status  
Patient 73 (81) 
Caregiver 18 (19) 
Gender  
Male 27 (30) 
Female 64 (70) 
Age (years)b  
< 40 6 (7) 
40 -  49 18 (20) 
50 - 59 25 (29) 
60 - 69 25 (29) 
>70 13 (15) 
Time in Australia (years)  
<5 years 5 (6) 
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5 -10 20 (22) 
11 – 20 25 (27) 
>20 41 (45) 
Self-reported English 
proficiency  
Very good – good 29 (23) 
Not very good -poor 62 (68) 
Cancer Type  
Breast 32 (35) 
Colorectal 7 (8) 
Lung 6 (7) 
Othera 46 (50) 
Stage  
Local 65 (71) 
Metastatic 14 (15) 
Unknown 12 (14) 
aOther cancer types included nasopharyngeal, peritoneal, pancreatic, bladder, kidney, prostate, leukaemia, skin, 
ovarian, liverand stomach. b 4 participants did not disclose their age cDiagnosis and stage are reported both for patient 
participants and for carers (in the latter 
Participants’ narrative accounts of their cancer treatment highlighted a range of treatment 
decision-making experiences.  Further analysis to explore factors that influenced these differing 
experiences identified four main themes: (1) the perceived role of the patient in decision-making; 
(2) access to information and the impact of language; (3) cultural influences and (4) involvement 
of family.  
 
3.1 Theme 1: Perceived role of the patient in decision-making 
 Although participants’ highlighted a range of treatment decision-making experiences the 
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majority reported passive involvement in decision-making discussions. Participants across 
language groups perceived their doctor did not seek their opinion and many participants did not 
actively seek involvement in their treatment planning. For some, this passive role came about 
because they perceived the doctor, based on their expertise, was best placed to make treatment 
decisions on behalf of the patient. The patient’s role was to follow the doctor’s expert advice.  
 
It's up to the doctor from the very beginning to the end, whatever the doctor says we just 
follow... It leaves you no room for decision. I just feel that it's not up to me to decide, I am not a 
professional doctor so I have to rely on the doctor, whatever he tells me to do (004, Cantonese 
patient) 
Other participants saw their role as finding the most expert, experienced, senior doctor 
and having done this, they could then rely on the doctor to make the right decisions regarding 
cancer care and provide the best treatment available.  
…of course we want to find the best doctor to see me, I don’t need someone who can 
speak Cantonese, we want the best doctor who can treat me (049 Cantonese patient). 
A few participants were less satisfied with their passive role during consultations and 
reported that they wanted to be involved in decision-making; however, perceived their doctor did 
not take their opinion or requests into consideration. These participants expressed their 
frustration at being excluded from decision-making. 
For my case, the specialist never discussed with me, never took my opinion in 
consideration... The doctor won’t listen to you. It’s not that we didn’t want, and it’s not that we 
didn’t initiate to know more, I really wanted to know, I felt helpless, felt myself helpless. He 
“HOLD” the “POWER”. (013, Mandarin patient) 
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In contrast to taking a passive role during consultations, and consistent with a shared 
decision-making model of care, some participants perceived they were actively involved in 
decision-making. They saw the doctor's opinions as recommendations and that both the patient 
and the doctor worked together to come to a decision. They perceived their opinions held equal 
weight as the doctor’s and their role in the discussion was to weigh up the options regarding 
which treatment option was most appropriate for their individual circumstances. 
...I feel that patients in Australia usually have right of choice... So I think sometimes the 
doctor can give you choice... It means you have choice of treatment. (003, Cantonese patient) 
 
3.2. Theme 2: Access to Information: too much or not enough?  
  Across language groups, access to information was a key issue influencing the role 
patients were able to play in treatment decision-making. The majority of participants reported the 
doctor gave less information than they had wanted, with approximately half of the participants 
reporting they had insufficient information about diagnosis and prognosis, reducing their 
understanding of their medical situation and hence their ability to be involved in treatment 
decision-making.  
I asked him (doctor) how long I will live. ... The doctor won’t answer me. He said ‘you 
keep on taking the medication’. (023, Cantonese patient) 
When I had to do chemotherapy I did it. The doctor said it and I did it…No (I did not 
consider another treatment) because I did not know if others existed. (015, Greek patient) 
In contrast, some participants reported that their doctor provided sufficient information 
for them to make treatment decisions, which helped participants feel a sense of control over what 
was happening to them.  
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I feel more secure … he (doctor) explain it very clearly, very detailed.. So I will be well prepared. 
(047, Cantonese patient). 
For a few participants, the limited information provided was based on patient choice. These 
participants preferred that the doctor, or in some cases the family, made treatment decisions and 
perceived the provision of too much information as distressing. 
I was so shocked and he gave me all this information! (laughs)... I don’t want to hear, prefer to 
be in the dark and someone else understands for me and that’s it, … the patient really doesn’t 
need to know, for me when he told me I was shocked and scared and left him (doctors surgery) 
straight away. ... I would prefer it if the doctor did not discuss this. (084, Arabic patient) 
Participants who perceived they received less information than they wanted used a 
number of strategies to facilitate their understanding of treatment choices. Some participants did 
not have the knowledge to understand the options, so sought second opinions from other experts 
on the treatment recommendations of the treating doctor. This extended to seeking second 
opinions from doctors in their country of birth, as participants placed trust in the health systems 
more familiar to them. Seeking a second opinion can also be considered an extension of the 
patient’s role of finding the ‘best’ doctor, as these participants reported the importance of 
reassurance that the treating team was well respected.  
No the doctor first tell me you need this… and then I asked the other doctors and they say 
this is the best so of course I come back and say I want to do it because they all say it’s the best. I 
don’t know what’s the best they do (089, Arabic patient)  
well I try to ask some doctors in my country back home, through my brothers there (077 
Arabic patient,) 
Many participants also reported they relied on the internet and social networks to 
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supplement the information received during consultations. These informal sources in the 
participant’s own language and often from participants’ country of birth, were perceived as 
trusted sources of information helpful to patient understanding, regardless of source. 
You can find it on the website in Chinese oncology hospital what you should take 
[treatment] they had it all (051 Cantonese patient) 
 
3.2.1 Language as a barrier to decision-making participation 
A major contributing factor to accessing information and therefore participation in 
treatment decision-making discussions was participants’ level of English proficiency. A lack of 
English was reported to greatly hinder both understanding and communication during treatment 
discussions. Even participants with some level of English struggled with understanding medical 
terminology and did not feel comfortable engaging in discussions where they were unsure of the 
meaning of terminology. 
Don’t know how to communicate. I want to talk about something but don’t know how to 
talk. The Caucasian think that you have nothing to ask, I feel it very hard to communicate my 
feelings (005, Cantonese patient) 
I can read English but I don’t understand the meaning of the words I have to take out the 
dictionary every time I come from the doctor’s. I just sit there and say yes, yes but I leave his 
consultation and I didn’t understand most things. I find it hard (094 Arabic patient). 
3.2.2 Does written information facilitate discussions? 
Given the language challenges during consultations, many participants reported a need 
for, and some expressed that they had expected to receive, written information to help understand 
their options and participate more fully in treatment decisions. Participants perceived that written 
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information could be shown to family members who understood English or translated at home. 
These participants highlighted a need for both general medical and individually tailored 
information including medical reports and scans.   
There was no “ANY WRITTEN REPORT SAYING WHAT IT WAS!!”(the patient stressed this in 
English). Until now I still don’t have. Never…Never anything in writing. (013, Mandarin patient) 
 
Some participants reported that written information was provided, but it was in English. 
These participants were distressed that information freely provided to English speaking patients 
was not available to them and perceived they were not fully informed of their choices. There 
were also some concerns raised about the quality of information available in patients’ own 
language. Participants reported that the information was often outdated, although English 
versions of the booklets had been updated. 
 I don’t understand English and everything they gave me was in English. No Greek person has 
spoken to me. Yes I have difficulties; I didn’t understand him in everything he said. (040, Greek 
patient) 
 
3.2.3 Seeking out those who speak my language 
Accessing doctors from the same cultural background was one way in which participants 
tried to overcome language barriers, however as there is no formal referral system, this was 
difficult, particularly if you were unfamiliar with the health system. Other participants made use 
of the interpreter services available. However, even when interpreters were present, several 
participants reported not being able to ask questions, to express their feelings and negotiate 
appointments, thus limiting their power in making decisions.  
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I made calls… I wanted to find one who spoke Chinese, its better for communication. Then I 
found Dr XXX speaks Chinese and his receptionist also spoke Chinese, then we could 
communicate. (005, Cantonese patient) 
For us it is difficult. As Chinese in overseas, when we have a problem, we can’t express our 
symptoms, so we find an interpreter. There are so many interpreters, they phone in. They don’t 
say it right [the meaning of what is being said]. So often our message is not correctly delivered. 
The doctor doesn’t understand us (023, Cantonese patient) 
Family members commonly accompanied participants with limited English to 
consultations to act as translators. However, despite being able to speak English, they often 
struggled to translate medical terminology. 
she [daughter] is educated here. She explains to us what he says… but there are medical 
terms, not everyone who just went to school here will understand these terms (037 Arabic carer). 
 
3.3. Theme 3: Cultural influences on decision making  
Exploration of the influence of culture on treatment decision-making highlighted that 
participants’ differing attitudes towards treatment options and the influence of religion, did play 
a role in how participants approached treatment decisions.  
 
3.3.1 Differing health concepts 
A number of Chinese-speaking participants highlighted that differences in attitude towards 
inclusion of traditional Chinese medicines as part of standard care made it hard for the doctors 
and participants to understand each other, and to reach agreement about treatment. These 
participants perceived their doctors provided less than optimal care if traditional treatments were 
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not considered or their value derided. These participants A few participants also reported they 
were distressed during treatment discussions as the options proposed were inconsistent with 
cultural norms within their birth country. 
 I take Chinese herb, I asked my doctor. The doctor didn’t agree with me at the beginning. 
for example during the chemotherapy,  the doctor told me I shouldn’t take anything,  but I felt it 
would be better. I took Ling-Zhi and shark bone powder now. (009, Mandarin patient) 
 
3.3.2 Impact of religious beliefs 
Religious beliefs also impacted on treatment decision-making for a number of 
participants. Some participants perceived that God was directing their fate with respect to disease 
outcomes. This led to nihilism and for one participant a delay in treatment, despite doctor 
recommendations. Several participants passively accepted the treatment plans provided to them 
by doctors because they perceived that the doctor was acting in God’s name. Others perceived 
that treatment options presented were inconsistent with their religious beliefs about the sanctity 
of the body. 
The doctor tells me to do something, you shouldn’t say ‘no, I won't do it’, this is in His 
[Gods] name, whatever they say, we do.(36, Arabic) 
The doctor told me, if you are worried you can take out the uterus...This kind of 
explanation for Chinese is a forbidden, we don’t talk about from a religious point of view, 
because when made human they give you in whole piece, they won't let you get rid of any organs 
easily... This might be to do with the Eastern and Western culture [difference] (079, Mandarin 
patient) 
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3.4. Theme 4: Involvement of family in decision-making 
  Consistent with non-migrant groups, participants described a range of family 
involvement in decision-making. Some participants discussed their treatment options with family 
and then made their own decisions, others did not involve family at all. However, participants 
from the Arabic groups generally held the view that family should make decisions on behalf of 
the patient, relieving the patient of the burden of having to weigh up options. Providing minimal 
information to patients was viewed as a means of protecting the patient from emotional distress. 
When patients who held this view were forced due to circumstance to decide for themselves, 
they reported significant pressure and feelings of being overwhelmed. For one participant, this 
resulted in delayed treatment and subsequent feelings of regret. This view was not as strongly 
held by Chinese and Greek patients. 
I told him (doctor) …‘don’t open your mouth, talk with my husband, talk with my children, and 
have a meeting with all of them… Don’t inform me, I don’t want to know, I am happy this way. 
(036, Arabic patient) 
 
4. Discussion and Conclusion 
4.1. Discussion 
  This study provides new insights into the influence of language and culture on the 
treatment decision-making experiences of migrants with cancer and their families within the 
Australian cancer care system.  Participants described a range of decision-making experiences, 
although the majority of participants experienced passive involvement during treatment 
consultations. Language rather than culture was a greater obstacle to active participation, with 
difficulties with communicating effectively in English reported as the most significant barrier to 
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participation in treatment decisions. To address this challenge, participants who wanted active 
involvement highlighted seeking second opinions, accessing information from informal sources, 
trying to find doctors who spoke their language and utilizing interpreters as strategies they 
frequently used to increase their ability to participate in treatment decision-making. Cultural 
factors such as differing attitudes towards treatment, the influence of religion and family 
involvement also influenced participants’ tendency to be involved in treatment decisions. 
The range of decision-making experiences reported in this study highlights different 
perceptions regarding the role of patients in deciding treatment. For some participants, the role of 
the patient was perceived to be that of a compliant patient who followed the doctor’s expert 
advice. Other participants saw their role as finding the doctor best placed to treat their cancer and 
having done this, it was the patient’s responsibility to follow the treatment plan. A smaller 
number of participants engaged in collaborative discussions with their doctors and defined their 
role as providing their unique perspective to the discussion regarding their individual 
circumstances.  
Access to information was the primary driver in participants’ ability to participate in 
treatment decisions and having unmet information needs was a source of frustration. Consistent 
with previous studies, an inability to communicate effectively resulted in limited exchange of 
information [8, 14]. To facilitate involvement and in contrast to the common cultural stereotype 
that migrant patients avoid disclosure, many patients in our study actively collected information 
in their language via the internet and their social networks. Across the language groups, patients 
also sought second opinions to ensure they received the most appropriate treatment and explored 
alternative treatments. They also sought out doctors who spoke their language and actively 
engaged with interpreter services, albeit with limited success. This suggests a strong desire to 
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contribute to treatment decisions. 
  
Consistent with this view, participants reported they wanted greater involvement in 
decision-making but perceived they were denied the opportunity. In contrast to best practice 
guidelines [15], these participants perceived their opinions were not sought or taken into 
consideration by their doctors. For example, differing cultural views on use of traditional 
treatment were often not discussed or patient beliefs disregarded. This suggests when language is 
a barrier, some doctors may revert to a paternalistic model of care, overlooking their patient's 
desire for involvement. However, inconsistency between patient decision-making preferences 
and experiences is not unique to migrants, with a number of studies in a general breast cancer 
population finding less than half of patients (50% and 34% respectively), reach their desired 
level of participatory communication regarding decision-making [16-18]. Doctors therefore need 
to place greater emphasis on determining patient preferences for involvement, and take 
additional time during such discussions with migrant patients, due to the challenge of language 
differences. 
  
Religious beliefs were also found to impact on treatment decision-making. For some 
patients, particularly those from Arabic backgrounds, treatment outcome was perceived as 
determined by God’s will. These participants perceived treatment decision-making to be futile, as 
the future was in the hands of God. This is consistent with previous studies that have reported 
that some migrant groups attribute a cancer diagnosis as an act of God [6], a view seldom 
reported by Anglo-Australian patients. Differing attitudes to effective treatments between doctors 
and patients mean it can be difficult to reach consensus in treatment discussions. 
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Families can also play a significant role in migrant patients’ decision making, [11, 19] 
acting as gatekeepers to protect patients from distress and having to make difficult decisions. In 
our study patients provided a range of expectations for family involvement. Some patients held 
the traditional view that it was the families’ responsibility to protect patients from unnecessary 
emotional burden by making decisions on their behalf, although, however the majority preferred 
to make their own decisions, often in consultation with family. This view was inconsistent with 
previous studies in Australia [11, 14].  To ensure consultations are tailored to individual patient 
need, our study findings suggest it is necessary for doctors to ask patients about family 
involvement at the beginning of discussions.  
 
 This study is the first comprehensive investigation of migrant cancer patient experiences 
and preferences for treatment decision-making in Australia. However, the results need to be 
considered in light of a number of limitations. Firstly, as the focus groups and interviews were 
completed prior to analysis, we were unable to explore emerging themes further with patients. 
Participants also self-selected to participate so generalizability to other non-participating migrant 
groups is difficult. Similarly, as the data was self-report, objective measures are also needed in 
future studies to determine whether the answers provided reflect actual practice during 
consultations.   
 
4.2. Conclusion 
  Migrant cancer patients participating in this study reported wanting to participate in 
treatment decision-making. Language rather than culture was a greater determinant of active 
17 
 
participation. To overcome the challenges associated with unmet information needs, patients and 
families actively sought second opinions and used informal sources to access information. 
Cultural differences such as views on traditional treatments and role of religion and families with 
respect to decision-making were perceived as secondary concerns when communication 
language was limited. The results of this study highlight the need for further investigation of the 
interplay between language and culture to optimize patient participation in treatment decision-
making. 
 
4.3. Practice Implications 
  To ensure patients are able to participate in treatment decision-making, appropriate 
resources in the patient’s language are recommended. Migrant patients are likely to need 
additional time, support and information to be able to participate in decision-making due to 
language difficulties. Doctors also need to be aware of cultural issues, and be sensitive and 
mindful of patients' diversified preferences regarding treatment decision making. 
 
I confirm all patient/personal identifiers have been removed or disguised so the patient/person(s) 
described are not identifiable and cannot be identified through the details of the story.  
18 
 
References 
1. Charles C, Gafni A and Whelan T. Decision-making in the physician–patient encounter: 
revisiting the shared treatment decision-making model. Soc Sci & Med, 1999; 49: 651-
61. 
 
2. Schouten BC, Meeuwesen L, Tromp F, Harmsen HAM. Cultural diversity in patient 
participation: The influence of patients’ characteristics and doctors’ communicative 
behaviour. Patient Educ and Couns, 2007. 67: p. 214-23. 
 
3. Gordon D. Embodying illness, embodying cancer. Cult, Med & Psych, 1990. 14: 275-97. 
 
4. Epstein RM & Peters E. Beyong information. Exploring patients’ preferences. JAMA 
2009. 302: 195-7. 
 
 
5. Wang JH, Adams IF, Pasick RJ, Gomez SL, Allen L, Ma GX, Lee MX, Huang 
E.Perceptions, expectations, and attitudes about communication with physicians among 
Chinese American and non-Hispanic white women with early stage breast cancer. Supp 
Care Cancer, 2013. 21: p. 3315-25. 
 
6. Saleh M, Barlow-Stewart K, Meiser B, Tucker K, Eisenbruch M, Kirk J. Knowledge, 
attitudes and beliefs of Arabic-Australians concerning cancer. Psycho-Oncology, 2012. 
21: 195-202. 
 
7. Obeidat RF, Homish GG, and Lally RM. Shared Decision Making Among Individuals 
With Cancer in Non-Western Cultures: A Literature Review. Onc Nurs Forum, 2013. 40: 
454 -63. 
 
8. Suurmond & Seeleman C. Shared decision-making in an intercultural context: Barriers 
in the interaction between physicians and immigrant patients. Patient Educ Couns, 2006; 
60: 253-59. 
 
9. Gordon, H.S., et al., Racial Differences in Trust and Lung Cancer Patients' Perceptions 
of Physician Communication. Journal of Clinical Oncology, 2006. 24(6): p. 904-909. 
 
 
10. Nguyen, G., et al., Cancer and Communication in the Health Care Setting: Experiences 
of Older Vietnamese Immigrants, A Qualitative Study. Journal of General Internal 
Medicine, 2008. 23(1): p. 45-50. 
 
11. Goldstein D, Thewes B, Butow P. Communicating in a multicultural society II: Greek 
community attitudes towards cancer in Australia. Intern Med, 2002; 32: 289-96. 
 
12. Mitchison D, Butow P, Sze M, Aldridge L, Hui R, Vardy J, Eisenbruch M, Iedema R, 
Goldstein D. Prognostic communication preferences of migrant patients and their 
relatives. Psycho-Oncology, 2012; 21: 496-504. 
19 
 
 
13. Australian Bureau of Statistics 2071.0 - Reflecting a Nation: Stories from the 2011 
Census, 2012–2013.  http://www.abs.gov.au/ausstats/abs@.nsf/ viewed July 2013. 
 
 
14. Huang X, Butow P, Meiser B, Goldstein D. Attitudes and information needs of Chinese 
migrant cancer patients and their relatives. ANZ J Med, 1999; 29: 207-13. 
 
 
15. Turner J, Zapart S, Pedersen K, Rankin N, Luxford K, Fletcher J. Clinical practice 
guidelines for the psychosocial care of adults with cancer. Psycho-Oncology, 2005. 14: 
159-73. 
 
16. Degner LF & Sloan JA. Decision making during serious illness: What role do patients 
really want to play? J Clin Epidemiol. 1992; 45: 941-50. 
 
17. Gattellari M, Butow PN, & Tattersall MHN. Sharing decisions in cancer care. Soc Scie 
& Med, 2001; 52:1865-78. 
 
18. Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC. Treatment Decision 
Making in Early-Stage Breast Cancer: Should Surgeons Match Patients’ Desired Level of 
Involvement? J Clin Onc, 2002. 20: 1473-79. 
 
19. Maly RC, Umezawa Y, Ratliff CT, Leake B. Racial/ethnic group differences in treatment 
decision-making and treatment received among older breast carcinoma patients. Cancer, 
2006; 106: 957-65. 
 
 
 
 
 
